6 results about "Oxime" patented technology

Provided are an oxime compound represented by General Formula (1), a photosensitive composition containing the oxime compound as a photopolymerization initiator, a production method for a color filter using the photosensitive composition, and a color filter obtained by the production method:

The invention relates to a ketonic oxime type silicone sealant and a preparation method thereof. The ketonic oxime type silicone sealant comprises the following raw material components in parts by weight: 100 parts of dyhydroxy polysiloxane, 40-80 parts of dimethyl silicon oil, 0.5-2 parts of a component A, 0.5-2 parts of a component B, 15-25 parts of packing, 5-12 parts of a cross-linking agent,0.5-3 parts of a silane coupling agent and 0.05-0.5 part of a catalyst, wherein the component A comprises nanosilver supported by a carrier; the component B comprises a thiazole compound. The ketonicoxime type silicone sealant is not liable to yellowing, good in anti-mold effect, short in surface dry and curing time and convenient to construct.

The invention provides a colored photosensitive resin composition, a color filter and an image display device, which are produced from the colored photosensitive resin composition. The colored photosensitive resin composition includes a colorant, a binding agent resin, a photo-polymerizable compound, a photo-polymerization initiator, and a solvent, wherein the photo-polymerization initiator includes an oxime compound which has absorption band at a zone of higher than 300 nm and an acetophenone compound which has absorption band at a zone of lower than 300 nm. The colored photosensitive resin composition can be fully cured even through a low-temperature sintering step. The color filter formed therewith has excellent solvent resistance, and is free of water strips and lamination residues.

The invention discloses an oleanolic acid oxime ester derivative and a preparation method and application thereof. According to the invention, oleanolic acid is taken as a raw material, a series of derivatives are synthesized through oxime esterification, lead compounds with good biological activity are obtained, and the synthesized OA derivative shows a glycosidase inhibition effect far higher than that of OA and has important biological activity. The oleanolic acid (OA) oxime ester derivative has a remarkable inhibition effect on the activity of alpha-glucosidase and alpha-amylase, the inhibition effect of the compound 3a on the alpha-glucosidase is the strongest, and IC50 is 0.35 mu M and is about 1900 times stronger than that of acarbose; the compound 3f has the strongest inhibition effect on alpha-amylase, and IC50 is 3.80 mu M and is about 26 times higher than acarbose. Researches show that the oleanolic acid oxime ester derivatives have reversible inhibition mechanisms and mixed inhibition mechanisms on alpha-glucosidase and alpha-amylase respectively.

A colored curable composition including: (A) a pigment dispersion containing (a-1) a pigment, (a-2) a compound having a pigment mother nucleus structure and an amino group in a molecule, and (a-3) a resin having an acid group and a polymerizable group; (B) an oxime ester initiator; and (C) a polymerizable compound.

A medication, a pharmaceutical composition, and method for the treatment of respiratory poisoning in animals and humans caused by organophosphorus compounds, whereby said medication and said pharmaceutical composition comprise at least one oxime and one blocker of organic cation transporters (OCT).